"Itovebi is the first treatment of its kind to improve survival outcomes for those living with PIK3CA-mutated, ER-positive advanced breast cancer," said Levi Garraway, MD, PhD, Roche's Chief Medical Officer and Head of Global Product Development. "Therefore, the Itovebi-based regimen may help address an important unmet need for people with this subtype of breast cancer." The approval is based on results from the phase III INAVO120 trial, published in the New England Journal of Medicine in October 2024, whic ...

PRESS RELEASEJuly 23, 2025 RENAULT GROUP BRANDS STAY THE COURSE IN A CHALLENGING ENVIRONMENT Renault Group recorded an increase in its overall sales in the first half of 2025 (+1.3% vs 2024), reaching 1,169,773 vehicles sold.Internationally1, the Renault brand grew by 16.3% with the commercial success of the first models of the International Game Plan.In Europe2, in a passenger car (PC) market down by 1.0%, the Group grew by 5.4% and reached 708,106 registered vehicles. Sandero and Clio are the two top-sell ...

HIAB CORPORATION, HALF-YEAR FINANCIAL REPORT JANUARY–JUNE 2025, 23 JULY 2025 AT 8:00 AM (EEST) Unless otherwise stated, the financial information in this report concerns Hiab's continuing operations. This half-year report is unaudited. April–June 2025 in brief: Orders received increased January–June 2025 in brief: Operating profit increased Hiab's half-year financial report January–June 2025: Strong performance in the first half Key takeaways from the quarter Outlook for 2025 specified Hiab estimates its co ...

Core Viewpoint - Equinor is set to commence the third tranche of its share buy-back program for 2025, amounting to up to USD 1,265 million, with a specific focus on purchasing shares worth up to USD 417.5 million in the market [1][2]. Group 1: Share Buy-Back Program Details - The total share buy-back program for 2025 is up to USD 5 billion, which includes shares to be redeemed from the Norwegian State, and is structured into tranches [2]. - The third tranche will be executed under a non-discretionary agreement with a third party, allowing independent trading decisions [2]. - The maximum number of shares that can be purchased in the market is 84 million, with 67,622,812 shares remaining available at the start of the third tranche [5]. Group 2: Cancellation and Redemption Process - All shares purchased in the third tranche will be cancelled through a capital reduction at the annual general meeting in May 2026 [4]. - The Norwegian State will vote for the cancellation of shares purchased in the market and redeem a proportionate number of its shares to maintain a 67% ownership stake [6][8]. Group 3: Regulatory Compliance - Share purchases will be conducted on the Oslo Stock Exchange and possibly other trading venues within the EEA, adhering to applicable safe harbour conditions and regulations [7]. - The board of directors will propose the cancellation of shares purchased in the third tranche at the annual general meeting in May 2026 [8].

Core Points - Equinor (OSE: EQNR, NYSE: EQNR) has announced a cash dividend of 0.37 USD for the second quarter of 2025 [1] - The last day to include rights for the dividend is 12 November 2025 [1] - The ex-date for Oslo Børs is 13 November 2025, and for the New York Stock Exchange, it is 14 November 2025 [1] - The record date for the dividend is set for 14 November 2025 [1] - The payment date for the dividend is scheduled for 26 November 2025 [1] - The approval date for the dividend was 22 July 2025 [1] - The cash dividend per share in NOK will be communicated on 20 November 2025 [1] Regulatory Compliance - The information is published in accordance with the Euronext Oslo Børs Continuing Obligations [2] - It is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act [2]

Financial Performance - Equinor reported an adjusted operating income of USD 6.53 billion and an adjusted net income of USD 1.67 billion for Q2 2025, leading to adjusted earnings per share of USD 0.64 [1][8] - The net operating income decreased to USD 5.72 billion from USD 7.66 billion in the same quarter last year, impacted by an impairment of USD 955 million due to regulatory changes [9] - Cash flows from operating activities before taxes and working capital items amounted to USD 9.17 billion for the quarter [10] Production and Operational Highlights - Total equity production reached 2,096 mboe per day, a 2% increase from 2,048 mboe in Q2 2024 [4] - The US onshore assets contributed to a 28% increase in oil and gas production compared to the same period last year [5] - The Johan Castberg field reached production plateau shortly after starting operations, contributing to strong operational performance [14] Strategic Developments - Equinor is progressing its renewable energy portfolio, with financial closure on the Baltyk 2 and 3 offshore wind projects in Poland, totaling EUR 6 billion [16] - The company announced the divestment of the Peregrino field in Brazil for USD 3.5 billion, focusing on the Bacalhau field start-up expected later in 2025 [15] - A long-term gas sales agreement was signed with Centrica for 55 TWh of natural gas per year over ten years, emphasizing the importance of gas supplies from the Norwegian continental shelf [14] Capital Distribution - An ordinary cash dividend of USD 0.37 per share was declared, with an expected total capital distribution of USD 9 billion for 2025, including a share buy-back program of up to USD 5 billion [17][18] - The third tranche of the share buy-back program, valued at up to USD 1.265 billion, is set to commence on July 24, 2025 [18]

Core Insights - The 2025 China International Fair for Trade in Services (CIFTIS) is scheduled to take place from September 10 to 14 at Shougang Park in Beijing, marking a significant event in the trade in services sector [1] - CIFTIS serves as a key global platform aimed at enhancing international collaboration, gathering global insights, and showcasing the latest achievements and emerging trends in the trade in services industry [1] - The event is expected to contribute positively to the recovery and growth of the global economy by injecting fresh momentum into the sector [1]

Core Viewpoint - Grupo Aeroportuario del Pacífico (GAP) reported significant growth in revenues and passenger traffic for the second quarter of 2025 compared to the same period in 2024, driven by increased aeronautical and non-aeronautical services, despite a decrease in comprehensive income due to foreign currency translation losses. Financial Position - As of June 30, 2025, the company had cash and cash equivalents of Ps. 9,697.3 million, repaid Ps. 2,500.0 million in maturing bonds, and drew down a Ps. 3,375.0 million credit facility from Banamex [3]. Passenger Traffic - In 2Q25, GAP's 14 airports saw an increase of 624.7 thousand total passengers, a 4.1% rise compared to 2Q24 [4]. - New domestic routes were launched by Viva, including daily flights between Hermosillo and Tijuana, and La Paz and Santa Lucía, among others [4]. - Internationally, World2Fly launched a weekly flight from Montego Bay to Lisboa [5]. Revenue Growth - Total revenues increased by Ps. 3,623.0 million, or 49.9%, with aeronautical services revenues rising by Ps. 1,202.2 million (26.4%) and non-aeronautical services revenues increasing by Ps. 719.9 million (41.8%) [7][16]. - Revenues from improvements to concession assets surged by Ps. 1,700.8 million, or 174.4% [16][18]. Cost and Operating Expenses - Total operating costs rose by Ps. 2,555.4 million, or 68.2%, primarily due to a significant increase in costs related to improvements to concession assets [19][33]. - Employee costs increased by Ps. 134.2 million (30.8%), and maintenance costs rose by Ps. 77.1 million (54.5%) [22]. Income and Profitability - Income from operations increased by Ps. 1,067.6 million, or 30.4%, with an EBITDA increase of Ps. 1,305.2 million (31.1%) [7][24]. - Comprehensive income decreased by Ps. 658.9 million, or 22.8%, primarily due to increased foreign currency translation losses [25][26]. Comprehensive Income and Margins - The operating income margin fell from 48.4% in 2Q24 to 42.1% in 2Q25, while the EBITDA margin decreased from 57.8% to 50.6% [24][37]. - Comprehensive income per share decreased from Ps. 5.7273 to Ps. 4.4232, reflecting a 22.8% decline [12].

Core Insights - DMG Blockchain Solutions Inc. is enhancing its treasury management capabilities through a regulated custody platform operated by its subsidiary, Systemic Trust Company [1][2] - The company is currently focused on managing a digital asset portfolio primarily consisting of bitcoin, with potential plans to diversify into other digital assets [2][3] - DMG is ranked 54 among Top Public Bitcoin Treasury Companies, indicating its position in the market [2] Group 1: Company Initiatives - DMG has engaged a consultant to implement institutional-grade treasury management within its custody platform [1] - The company aims to leverage its existing bitcoin holdings and proceeds from Bitcoin mining to support its treasury management efforts [2] - DMG's CEO highlighted the shift in investor interest towards actively managed digital asset strategies rather than traditional ETFs [3] Group 2: Systemic Trust Company - Systemic Trust is fully regulated under the Alberta Loans and Trust Corporations Act, ensuring high standards of compliance and security for client digital assets [4] - The company combines regulatory compliance with advanced technology and robust insurance to enhance the digital asset custody experience [4] Group 3: Company Overview - DMG is a vertically integrated blockchain and data center technology company focused on monetizing digital assets and AI compute ecosystems [5] - The company operates a carbon-neutral Bitcoin ecosystem, facilitating sustainable and regulatory-compliant Bitcoin transactions for financial institutions [5]

Core Insights - IDEX Biometrics ASA conducted a private placement of 9,090,909 shares at NOK 3.30 per share, divided into two tranches [1] - The first tranche involved the subscription of 4,731,594 shares by primary insiders, including the CEO and CFO, and companies closely related to them [1] Group 1: Private Placement Details - The CEO and CFO, Anders Storbråten, subscribed to 443,616 shares at NOK 3.30 per share [1] - Pinchcliffe AS, associated with Anders Storbråten, subscribed to 295,744 shares at the same price [1] - K-konsult AS, linked to chair Morten Opstad, subscribed to 128,156 shares at NOK 3.30 per share [1] Group 2: Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [2] - The company's biometric solutions are based on patented sensor technologies and target card-based applications for payments and digital authentication [2] - IDEX partners with leading card manufacturers and technology companies to bring its solutions to market [2]